Goodyear Tire & Rubber Valuation
Is GT * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GT * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: GT * (MX$170) is trading above our estimate of fair value (MX$25.96)
Significantly Below Fair Value: GT * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GT *?
Other financial metrics that can be useful for relative valuation.
What is GT *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$2.35b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.6x |
Enterprise Value/EBITDA | 6.2x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does GT *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.4x | ||
NEMAK A Nemak S. A. B. de C. V | 0.07x | 1.5% | Mex$6.5b |
GISSA A Grupo Industrial Saltillo. de | 0.3x | 10.3% | Mex$5.3b |
5110 Sumitomo Rubber Industries | 0.3x | 2.5% | JP¥404.8b |
000887 Anhui Zhongding Sealing Parts | 1x | 13.8% | CN¥18.3b |
GT * Goodyear Tire & Rubber | 0.1x | 0.3% | Mex$2.3b |
Price-To-Sales vs Peers: GT * is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (0.4x).
Price to Earnings Ratio vs Industry
How does GT *'s PE Ratio compare vs other companies in the Global Auto Components Industry?
Price-To-Sales vs Industry: GT * is good value based on its Price-To-Sales Ratio (0.1x) compared to the Global Auto Components industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is GT *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.1x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate GT *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$170.00 | Mex$260.22 +53.1% | 30.3% | Mex$378.87 | Mex$177.47 | n/a | 6 |
Oct ’25 | Mex$161.90 | Mex$255.53 +57.8% | 28.8% | Mex$367.34 | Mex$172.07 | n/a | 6 |
Sep ’25 | n/a | Mex$259.12 0% | 23.0% | Mex$361.01 | Mex$169.11 | n/a | 8 |
Aug ’25 | Mex$185.56 | Mex$270.29 +45.7% | 14.8% | Mex$341.79 | Mex$215.87 | n/a | 8 |
Jul ’25 | n/a | Mex$279.65 0% | 15.6% | Mex$350.88 | Mex$221.61 | n/a | 7 |
Jun ’25 | n/a | Mex$257.79 0% | 16.3% | Mex$319.43 | Mex$201.75 | n/a | 6 |
May ’25 | n/a | Mex$265.19 0% | 15.2% | Mex$324.18 | Mex$204.75 | n/a | 7 |
Apr ’25 | Mex$219.23 | Mex$265.19 +21.0% | 15.2% | Mex$324.18 | Mex$204.75 | n/a | 7 |
Mar ’25 | Mex$202.00 | Mex$265.19 +31.3% | 15.2% | Mex$324.18 | Mex$204.75 | n/a | 7 |
Feb ’25 | Mex$252.36 | Mex$284.09 +12.6% | 14.8% | Mex$360.94 | Mex$223.44 | n/a | 7 |
Jan ’25 | n/a | Mex$286.47 0% | 15.9% | Mex$366.83 | Mex$227.08 | n/a | 7 |
Dec ’24 | n/a | Mex$281.65 0% | 17.2% | Mex$362.12 | Mex$224.17 | n/a | 6 |
Nov ’24 | n/a | Mex$265.24 0% | 10.3% | Mex$310.97 | Mex$237.80 | n/a | 6 |
Oct ’24 | n/a | Mex$244.38 0% | 11.9% | Mex$289.85 | Mex$204.60 | Mex$161.90 | 6 |
Sep ’24 | Mex$216.20 | Mex$244.38 +13.0% | 11.9% | Mex$289.85 | Mex$204.60 | n/a | 6 |
Aug ’24 | Mex$273.16 | Mex$258.92 -5.2% | 15.8% | Mex$320.84 | Mex$219.52 | Mex$185.56 | 6 |
Jul ’24 | Mex$230.00 | Mex$270.20 +17.5% | 15.4% | Mex$338.49 | Mex$231.60 | n/a | 6 |
Jun ’24 | Mex$253.05 | Mex$270.20 +6.8% | 15.4% | Mex$338.49 | Mex$231.60 | n/a | 6 |
May ’24 | n/a | Mex$238.92 0% | 20.8% | Mex$305.71 | Mex$161.85 | n/a | 7 |
Apr ’24 | Mex$188.10 | Mex$247.88 +31.8% | 23.4% | Mex$317.18 | Mex$167.92 | Mex$219.23 | 7 |
Mar ’24 | n/a | Mex$247.88 0% | 23.4% | Mex$317.18 | Mex$167.92 | Mex$202.00 | 7 |
Feb ’24 | Mex$210.00 | Mex$254.72 +21.3% | 20.4% | Mex$319.08 | Mex$168.92 | Mex$252.36 | 7 |
Jan ’24 | Mex$188.00 | Mex$278.37 +48.1% | 17.1% | Mex$334.60 | Mex$196.82 | n/a | 7 |
Dec ’23 | Mex$218.00 | Mex$278.37 +27.7% | 17.1% | Mex$334.60 | Mex$196.82 | n/a | 7 |
Nov ’23 | Mex$220.00 | Mex$336.87 +53.1% | 20.1% | Mex$440.39 | Mex$240.21 | n/a | 7 |
Oct ’23 | Mex$205.00 | Mex$350.50 +71.0% | 17.7% | Mex$439.55 | Mex$279.72 | n/a | 7 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.